NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+2.46%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.36B
AUM Growth
-$126M
(-5.1%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
4.42%
Top 10 Holdings %
Top 10 Hldgs %
55.13%
Holding
55
New
9
Increased
3
Reduced
6
Closed
1
Top Buys
| 1 |
Nkarta
NKTX
|
$87.3M |
| 2 |
Annexon
ANNX
|
$75.5M |
| 3 |
INZY
Inozyme Pharma
INZY
|
$64.3M |
| 4 |
MTCR
Metacrine, Inc. Common Stock
MTCR
|
$31.3M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$24.3M |
Top Sells
| 1 |
Sprout Social
SPT
|
$133M |
| 2 |
CRISPR Therapeutics
CRSP
|
$41.9M |
| 3 |
Mersana Therapeutics
MRSN
|
$37.2M |
| 4 |
Rigel Pharmaceuticals
RIGL
|
$5.94M |
| 5 |
Cloudflare
NET
|
$5.32M |
Sector Composition
| 1 | Healthcare | 83.31% |
| 2 | Technology | 10.27% |
| 3 | Consumer Discretionary | 1.95% |
| 4 | Industrials | 1.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKTX
51
Akari Therapeutics
AKTX
$21.4M
| $787K | 0.03% |
22,608
| – | – |
|
52
Palantir
PLTR
$367B
| $712K | 0.03% |
+74,974
| New | +$712K |
|
|
ALTR
53
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $503K | 0.02% |
+11,977
| New | +$503K |
|
|
VIRX
54
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $162K | 0.01% |
37,093
-1
| -0% | -$4 |
|
|
55
Rigel Pharmaceuticals
RIGL
$710M
| – | – |
-324,315
| Closed | -$5.94M |
|